Prognostic significance of minimal residual disease before post-remission therapy in younger adult acute myeloid leukemia patients with intermediate risk and negative of FLT3-ITD, NPM1 and biallelic CEBPA mutations.
10.3760/cma.j.issn.0253-2727.2019.07.012
- Author:
Ying ZHANG
1
,
2
;
Yi Min ZHANG
;
Yue Sheng ZHANG
;
Gu Sheng TANG
;
Wei Ping ZHANG
;
Jian Min YANG
;
Jian Min WANG
;
Xiao Xia HU
Author Information
1. Department of Hematology, Changhai Hospital, the Second Military Medical University
2. Institute of Hematologic Disease of Chinese PLA, Shanghai 200433, China.
- Publication Type:Journal Article
- MeSH:
Adult;
CCAAT-Enhancer-Binding Proteins/genetics*;
Humans;
Leukemia, Myeloid, Acute/genetics*;
Mutation;
Neoplasm, Residual/diagnosis*;
Nuclear Proteins/genetics*;
Nucleophosmin;
Prognosis;
Remission Induction;
fms-Like Tyrosine Kinase 3/genetics*
- From:
Chinese Journal of Hematology
2019;40(7):597-601
- CountryChina
- Language:Chinese
